Our Vision
The ICOD project, funded by European Union (EU) aims to develop the first pharmacological therapy for cognitive impairment in Down syndrome (DS) making it accessible to patients worldwide.
Know more
Consortium Partners
This project is the result of one of the biggest international collaborations in research of Down Syndrome, involving six different institutions from three European countries. Meet the team and learn how every partner is leading specific stages of the project.
Know more
News
From interesting news to upcoming congresses and highlighted events that we recommend you, this is your place! Stay tuned for the latest in Down Syndrome, and know before anyone else the updates in the ICOD Project.
Know more